Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

Watch this Webcast and download the slides from a CCO symposium at the 2019 CHEST Annual Meeting featuring experts in medical oncology radiation oncology and pulmonology discussing optimal integration of immune checkpoint inhibitors into the treatment of stage III NSCLC using a multidisciplinary approach.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca